Rajapreyar Prakadeshwari, Castaneda Lauren, Thompson Nathan E, Petersen Tara L, Hanson Sheila J
Department of Pediatric Critical Care, Medical College of Wisconsin, Milwaukee, WI, United States.
Children's Wisconsin, Milwaukee, WI, United States.
Front Pediatr. 2021 Sep 16;9:722477. doi: 10.3389/fped.2021.722477. eCollection 2021.
The effect of positive fluid balance (FB) on extracorporeal membrane oxygenation (ECMO) outcomes in pediatric patients remains unknown. We sought to evaluate if positive FB in pediatric intensive care unit (PICU) patients with respiratory and/or cardiac failure necessitating ECMO was associated with increased morbidity or mortality. This was a multicenter retrospective cohort study of data from the deidentified PEDiatric ECMO Outcomes Registry (PEDECOR). Patients entered into the database from 2014 to 2017, who received ECMO support, were included. A total of 168 subjects met the study criteria. Univariate analysis showed no significant difference in total FB on ECMO days 1-5 between survivors and non-survivors [median 90 ml/kg (IQR 18-208.5) for survivors vs. median 139.7 ml/kg (IQR 11.2-300.6) for non-survivors, = 0.334]. There was also no difference in total FB on ECMO days 1-5 in patients with no change in functional outcome as reflected by the Pediatric Outcome Performance Category (POPC) score vs. those who had worsening in POPC score ≥2 at hospital discharge [median 98 ml/kg (IQR 18-267) vs. median 130 ml/kg (IQR 13-252), = 0.91]. Subjects that required 50 ml/kg or more of blood products over the initial 5 days of ECMO support had an increased rate of mortality with an odds ratio of 5.8 (95% confidence interval of 2.7-12.3; = 0.048). Our study showed no association of the noted FB with survival after ECMO cannulation. This FB trend was also not associated with POPC at hospital discharge, MV duration, or ECMO duration. The amount of blood product administered was found to be a significant predictor of mortality.
正性液体平衡(FB)对儿科患者体外膜肺氧合(ECMO)治疗结局的影响尚不清楚。我们试图评估在因呼吸和/或心力衰竭而需要ECMO的儿科重症监护病房(PICU)患者中,正性FB是否与发病率或死亡率增加相关。这是一项对去识别化的儿科ECMO结局登记系统(PEDECOR)数据进行的多中心回顾性队列研究。纳入了2014年至2017年进入数据库且接受ECMO支持的患者。共有168名受试者符合研究标准。单因素分析显示,在ECMO治疗第1至5天,幸存者与非幸存者的总FB无显著差异[幸存者中位数为90 ml/kg(四分位间距18 - 208.5),非幸存者中位数为139.7 ml/kg(四分位间距11.2 - 300.6),P = 0.334]。根据儿科结局表现类别(POPC)评分,功能结局无变化的患者与出院时POPC评分恶化≥2分的患者在ECMO治疗第1至5天的总FB也无差异[中位数分别为98 ml/kg(四分位间距18 - 267)和130 ml/kg(四分位间距13 - 252),P = 0.91]。在ECMO支持的最初5天内需要50 ml/kg或更多血液制品的受试者死亡率增加,比值比为5.8(95%置信区间为2.7 - 12.3;P = 0.048)。我们的研究表明,上述FB与ECMO插管后的生存率无关。这种FB趋势也与出院时的POPC、机械通气持续时间或ECMO持续时间无关。发现血液制品的使用量是死亡率的一个重要预测因素。